Loading…

Molecular Structure of Binary Chromium(III)–DNA Adducts

Chromium(VI) is a carcinogen and mutagen, and its mechanisms of action are proposed to involve binding of its reduction product, chromium(III), to DNA. The manner in which chromium(III) binds DNA has not been established, particularly at a molecular level. Analysis of oligonucleotide duplex DNAs by...

Full description

Saved in:
Bibliographic Details
Published in:Chembiochem : a European journal of chemical biology 2020-03, Vol.21 (5), p.628-631
Main Authors: Brown, Silas, Lockart, Molly M., Thomas, C. Sumner, Bowman, Michael K., Woski, Stephen A., Vincent, John B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chromium(VI) is a carcinogen and mutagen, and its mechanisms of action are proposed to involve binding of its reduction product, chromium(III), to DNA. The manner in which chromium(III) binds DNA has not been established, particularly at a molecular level. Analysis of oligonucleotide duplex DNAs by NMR, EPR, and IR spectroscopies in the presence of chromium(III) allows the elucidation of the Cr binding site. The metal centers were found to interact exclusively with guanine N7 positions. No evidence of chromium interactions with other bases or backbone phosphates nor of Cr forming intra‐strand crosslinks between neighboring guanine residues was observed. No (back)bones about it: A combination of NMR, EPR, and FTIR spectroscopic studies demonstrate that chromium(III), the ultimate reduction product of the carcinogen chromate, forms binary adducts at the N7 atom of guanine with no binding to the phosphate backbone.
ISSN:1439-4227
1439-7633
DOI:10.1002/cbic.201900436